The UNC Eshelman School of Pharmacy is part of a robust research and teaching community at the University of North Carolina at Chapel Hill. Click here to view fast facts about the University.

Overview of the School

Click Here for a downloadable and printable version of the 2017 UNC Eshelman School of Pharmacy Fast Facts.

By the Numbers

611

Professional
students

102

Graduate
students

118

Full-time
faculty

$51 Million

In annual
expenditures

$27 Million

In research grants

$85 Million

In endowment

$7.5 Million

In private funds raised annually

86

Total active patents

22

Start-ups


Rankings

No. 1

Pharm.D. program as ranked by U.S. News & World Report

No. 2

Among schools and colleges of pharmacy in total research funding

No. 2

Among schools and colleges of pharmacy in NIH funding

No. 2

Best Global Universities in Pharmacology and Toxicology ranked by U.S. News & World Report

No. 10

Best World Universities in Pharmacy and Pharmacology in the 2016 QS World University Rankings


Mission and Scope

The UNC Eshelman School of Pharmacy is a nationally recognized leader in pharmacy practice, education, and research and boasts a world-class faculty, staff, and student body. The School has built a reputation for its rigorous education and training programs, cutting-edge multidisciplinary research, progressive pharmacy practices, and efficient business operations. The School’s mission is to develop leaders in pharmacy education, pharmacy practice, and pharmaceutical sciences who make a difference on human health worldwide.


Strategy, Innovation, and Transformation

The School has experienced unprecedented growth and transformation over the past ten years.

  • 23 percent increase in Pharm.D. students; 28 percent increase in graduate students
  • 63 percent increase in faculty
  • 92 percent increase in facility square footage
  • 206 percent increase in external funding
  • 54 percent increase in endowment
  • Second among schools and colleges of pharmacy in total federal research funding
  • Establishment of five research centers and the Carolina Partnership

The School continues to strategically position itself for continued growth and success, as articulated in the School’s Strategic Plan 2012–2017. The plan is framed around seven strategic initiatives. The School will invest in:

  • transforming our educational programs;
  • advancing the practice of pharmacy;
  • growing, differentiating, and translating the research enterprise;
  • cultivating global partnerships;
  • improving environment and operational efficiencies;
  • developing and advancing our people; and
  • fostering a culture of assessment and continuous quality improvement.

*as of May, 2015


Leadership, Administration, and Operations

Robert Blouin is dean of the UNC Eshelman School of Pharmacy. The School’s senior administration includes several executive and associate deans and five division chairs representing the School’s Divisions of Chemical Biology and Medicinal Chemistry, Molecular Pharmaceutics, Pharmacotherapy and Experimental Therapeutics, Pharmaceutical Outcomes and Policy, and Practice Advancement and Clinical Education.

The School’s business enterprise is based on a centralized model whereby subject-matter experts drive best practices and operational efficiencies. A cooperative matrix model is the backbone of the design, promoting collaboration across multiple divisions and units to support a complex business environment.